These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29891609)

  • 21. Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.
    Rodvold KA; Gotfried MH; Still JG; Clark K; Fernandes P
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5076-81. PubMed ID: 22802254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects.
    Darpo B; Sager PT; Fernandes P; Jamieson BD; Keedy K; Zhou M; Oldach D
    J Antimicrob Chemother; 2017 Feb; 72(2):515-521. PubMed ID: 27798210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solithromycin for the treatment of community-acquired bacterial pneumonia.
    Viasus D; Ramos O; Ramos L; Simonetti AF; Carratalà J
    Expert Rev Respir Med; 2017 Jan; 11(1):5-12. PubMed ID: 27753516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.
    Arzimanoglou A; Ferreira JA; Satlin A; Mendes S; Williams B; Critchley D; Schuck E; Hussein Z; Kumar D; Dhadda S; Bibbiani F
    Eur J Paediatr Neurol; 2016 May; 20(3):393-402. PubMed ID: 26805435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.
    Kersemaekers WM; van Iersel T; Nassander U; O'Mara E; Waskin H; Caceres M; van Iersel ML
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1246-51. PubMed ID: 25512407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
    Arrieta AC; Neely M; Day JC; Rheingold SR; Sue PK; Muller WJ; Danziger-Isakov LA; Chu J; Yildirim I; McComsey GA; Frangoul HA; Chen TK; Statler VA; Steinbach WJ; Yin DE; Hamed K; Jones ME; Lademacher C; Desai A; Micklus K; Phillips DL; Kovanda LL; Walsh TJ
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0029021. PubMed ID: 34031051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
    Walsh TJ; Karlsson MO; Driscoll T; Arguedas AG; Adamson P; Saez-Llorens X; Vora AJ; Arrieta AC; Blumer J; Lutsar I; Milligan P; Wood N
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2166-72. PubMed ID: 15155217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations.
    Kunze C; Mentzel HJ; Krishnamurthy R; Fleck R; Stenzel M; Bhargava R; Burrowes D; Sutter G; Schultze-Mosgau M; Santiuste M; Hahn G
    Invest Radiol; 2016 Jan; 51(1):50-7. PubMed ID: 26340504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study.
    Jiang LJ; Or YS
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3218-25. PubMed ID: 19451282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The solithromycin journey-It is all in the chemistry.
    Fernandes P; Martens E; Bertrand D; Pereira D
    Bioorg Med Chem; 2016 Dec; 24(24):6420-6428. PubMed ID: 27595539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and pharmacokinetics/pharmacodynamics of bendamustine in pediatric patients with relapsed/refractory acute leukemia.
    Darwish M; Megason G; Bond M; Hellriegel E; Robertson P; Grasela T; Phillips L
    Curr Med Res Opin; 2014 Nov; 30(11):2305-15. PubMed ID: 25105914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.
    Gounder MM; Zer A; Tap WD; Salah S; Dickson MA; Gupta AA; Keohan ML; Loong HH; D'Angelo SP; Baker S; Condy M; Nyquist-Schultz K; Tanner L; Erinjeri JP; Jasmine FH; Friedlander S; Carlson R; Unger TJ; Saint-Martin JR; Rashal T; Ellis J; Kauffman M; Shacham S; Schwartz GK; Abdul Razak AR
    J Clin Oncol; 2016 Sep; 34(26):3166-74. PubMed ID: 27458288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009).
    Farrell DJ; Castanheira M; Sader HS; Jones RN
    J Infect; 2010 Dec; 61(6):476-83. PubMed ID: 20831882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.
    Fasanmade AA; Adedokun OJ; Blank M; Zhou H; Davis HM
    Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, open-label, single-dose, crossover, relative bioavailability study in healthy adults, comparing the pharmacokinetics of rabeprazole granules administered using soft food or infant formula as dosing vehicle versus suspension.
    Thyssen A; Solanki B; Treem W
    Clin Ther; 2012 Jul; 34(7):1636-45. PubMed ID: 22748970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
    Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.
    Sandström M; Davidson G; Tolia V; Sullivan JE; Långström G; Lundborg P; Brown K
    Clin Ther; 2012 Aug; 34(8):1828-38. PubMed ID: 22832034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.